Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences
Director
Telephone: 412-586-9771

Black Breast Cancer Patients Given Appropriate Treatment Do As Well As Whites, Finds University of Pittsburgh Researcher

PITTSBURGH, January 14, 2000 — Black and white women with same-stage breast cancer see largely similar outcomes when their treatment and follow-up care are appropriate for their individual disease conditions, suggesting that physiological responses to treatments are not responsible for poorer outcomes among blacks. These findings are reported in a review paper by University of Pittsburgh researcher James J. Dignam, Ph.D., and published this week in the January-February issue of CA: A Cancer Journal for Clinicians, a journal of the American Cancer Society.

The review covered historic and recent research on breast cancer prognosis among black and white women, including investigations of clinical, pathologic, social, economic and demographic factors that may contribute to poorer outcomes for blacks.

"Results of this review suggest that treatments for breast cancer have the same results in black women as they do in white women at the same stage of disease when administered according to expert consensus, and that the reasons for blacks’ poorer prognoses lie elsewhere," said Dr. Dignam, research assistant professor in the University’s Graduate School of Public Health, and biostatistician for the National Surgical Adjuvant Breast and Bowel Project (NSABP).

Dr. Dignam’s review shows that the most important determinant of ultimate outcome in breast cancer patients is the stage of cancer at diagnosis, and blacks are more often diagnosed at a more advanced stage than are whites. Dr. Dignam suggested that possible reasons for this late diagnosis may be less access to or utilization of health care resources that would result in earlier detection, or more aggressive forms of the disease among black women.

"The bottom line is, early detection and appropriate follow-up therapy could appreciably reduce the disparity in outcome between black and white breast cancer patients," said Dr. Dignam. "Also, it is imperative that established therapies be uniformly delivered to all patients in accordance with their anticipated clinical prognosis."

When patients of the same stage are compared across racial lines, black women more often show characteristics associated with poorer prognosis, such as larger tumor size, greater nodal involvement and estrogen receptor negative tumors, the study shows. Even obesity, found to be more prevalent among black breast cancer patients, is associated with a more advanced stage, possibly due to obesity’s effect on estrogen, which can accelerate disease progression.

When national guidelines are followed, such indicators of poorer prognosis might call for more aggressive treatments, such as chemotherapy in addition to or instead of tamoxifen, according to Dr. Dignam. But some studies show that black women with these indicators are not undergoing the appropriate therapies. Studies in some urban hospitals, which are likely to treat the bulk of black breast cancer patients, have a greater rate of late-stage diagnosis as well as a higher degree of nonstandard care, including less frequent post-surgical radiation therapy and diagnostic tests used to choose appropriate therapy.

"Certain aspects of care differed according to factors such as age and race, with older and black patients less frequently receiving treatment in accordance with recommended guidelines," said Dr. Dignam.

When treatment was administered, studies show that black women were much more likely to have received total mastectomy rather than lumpectomy with radiation therapy in cases where either procedure would have been acceptable.

"One study showed frequency of breast-conserving surgery to be related to higher income and education, but in fact the relationship between blacks and total mastectomy may have many causes, including an institution’s lack of resources to provide adequate radiation therapy, and patient or physician preference," Dr. Dignam said.

Conversely, studies focusing on settings where national treatment guidelines were followed show similar outcomes between black and white patients at the same stage of disease, and roughly equal survival rates.

In an effort to foster better quality care across racial lines, the NSABP and other clinical trial groups have begun to encourage participation by blacks in randomized clinical trials.

"Encouragement by black scientists and community leaders would have immeasurable results in increasing the numbers of black women participating in these trials," Dignam said. "This in turn would help both the patients and the scientific community in its ability to assess the important public health question of why black women with breast cancer have a poorer survival rate than do white women."

This study was funded by grants from the National Cancer Institute and the American Cancer Society.

Established in 1948, the University of Pittsburgh Graduate School of Public Health (GSPH) is world-renowned for contributions that have influenced public health practices and medical care for millions of people. It is the only fully accredited school of public health in the Commonwealth of Pennsylvania and is one of the top-ranked schools of public health in the United States.

For more information about the GSPH, access http://www.publichealth.pitt.edu/.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com